Alivus Life Sciences fundamental analysis

ALIVUS

866.6

15.75 (-1.79%)
Last updated on 19 Jan, 2026 | 15:41 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Alivus Life Sciences Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.39

Sector P/B

0.98

Sec. Div. Yield

0.57

Alivus Life Sciences Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 69.39. Its P/B Ratio stands at 0, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.

Alivus Life Sciences Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Alivus Life Sciences reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.